Arkolith/Insider Trading/VRTX/Form 4

Ambrose Kristen

SVP & Chief Accounting OfficerVERTEX PHARMACEUTICALS INC / MA (VRTX) · full profile →Form 4 · filed Feb 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$108K
Net Open-Market Flow
-$108K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 25, 2026Sell(S)223$486.35$108K7K
Feb 24, 2026Tax withholding(F)546$485.11$265K7K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000875320-26-000104) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML